Diaphragmatic pacing is a treatment that improves breathing for people who rely on a mechanical ventilator. It stimulates the phrenic nerve, the nerve in your neck that sends signals to your diaphragm ...

The global Diaphragm Pacing Therapy System Market is experiencing growth, with projections indicating a continued upward trajectory and a compound annual growth rate (CAGR) of 4.06% through 2028.

Fifteen months following COVID-19 hospitalization, both ventilated and nonventilated patients displayed diaphragm muscle weakness, according to results published in American Journal of Respiratory ...

The NeuRX Diaphragm Pacing System costs hospitals $36,000, Ignagni said. He was unable to say what patients pay, because that cost varies from hospital to hospital.

Oberlin-based Synapse Biomedical recently secured U.S. Food and Drug Administration premarket approval for its diaphragm pacing system for use in patients with spinal cord injuries (SCI) who rely on ...

Synapse Biomedical has received premarket approval from the FDA for its NeuRx Diaphragm Pacing System, which aids adults with spinal cord injuries that require ventilation to breathe, according to ...

Synapse Biomedical's diaphragm pacing system has won premarket approval from the Food & Drug Administration.

OBERLIN, Ohio, April 5, 2023 /PRNewswire/ -- Synapse Biomedical, Inc. announced today that the FDA has granted premarket approval (PMA) of the NeuRx ® Diaphragm Pacing System (NeuRx DPS ®) for ...